Skip to search formSkip to main contentSkip to account menu

CD56 Antigens

Known as: CD56, Antigen, CD56, CD56 Ag 
The 140 kDa isoform of NCAM (neural cell adhesion molecule) containing a transmembrane domain and short cytoplasmic tail. It is expressed by all… 
National Institutes of Health

Related topics

Related topics

9 relations
CD56 Ag:PrThr:Pt:Tiss:Ord:Immune stainCD57 AntigensCells.CD56:NCnc:Pt:Bld:QnIn Blood

Broader (1)

Neural Cell Adhesion Molecules

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Application of CD 56 , P 63 and CK 19 immunohistochemistry in the diagnosis of papillary carcinoma of the thyroid
Papillary carcinoma of the thyroid (PTC) is the commonest thyroid cancer. In the recent decades an obvious increase in the… 
2012
2012
Primary Esophageal Small Cell Carcinoma with Brain Metastasis and with CD56, KIT, and PDGFRA Expressions
To the Editor KIT (CD117) is a product of an oncogene KIT mapped to 4q12 [1]. It is a transmembranous receptor tyrosine kinase… 
2007
2007
CD 56 Positive Intestinal T-Cell Lymphoma : Treatment with High Dose Chemotherapy and Autologous Peripheral Blood Stem Cell Transplantation
A 63-year-old man presented with a perforation of the small intestine. A diagnosis of intestinal T-cell lymphoma (ITCL) was made… 
Review
2003
Review
2003
CD 4 + CD 56 + lineage negative maligancies : a new entity developed from malignant early plasmacytoid dendritic cells
941 Background and Objectives. The CD4+ CD56+ lin− immunophenotype characterizes rare malignancies, so far considered as arising… 
2002
2002
Clinical and biologic features of CD 4 1 CD 56 1 malignancies
CD41CD561 malignancies are rare hematologic neoplasms, which were recently shown to correspond to the so-called type 2 dendritic… 
2000
2000
Pregnancy as a Model of Controlled Invasion Might Be Attributed to the Ratio of CD3/CD8 to CD56
PROBLEM: Pregnancy can be considered as a model of successfully controlled tissue invasion. Cellular mediated immunity appears to… 
1999
1999
Alteration of the PML proto-oncogene in leukemic cells does not abrogate expression of MHC class I antigens
Alteration of the PML proto-oncogene in leukemic cells does not abrogate expression of MHC class I antigens 
Highly Cited
1996
Highly Cited
1996
Utility of a paraffin section-reactive CD56 antibody (123C3) for characterization and diagnosis of lymphomas.
Although expression of CD56 (neural cell adhesion molecule, a natural killer cell marker) is uncommon among lymphomas, this… 
1994
1994
Adhesive properties of choriocarcinoma cells toward lymphocytes activated or not by interleukin-2.
Choriocarcinoma cells (CC) in vitro are resistant to NK lysis but sensitive to lysis by blood or decidual effectors activated by… 
1992
1992
NCAM (CD56)-positive malignant lymphoma.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)